0
0
AIIMS Delhi has taken a major leap in India’s cancer treatment landscape with the launch of an advanced robotic surgery program at the Dr. Bhim Rao Ambedkar Institute Rotary Cancer Hospital, Department of Surgical Oncology. Introduced in September 2025, the program centers on the da Vinci surgical system, designed to deliver greater precision in complex cancer surgeries—a move expected to shape care standards for thousands of patients across the country.
Advancing Cancer Surgery: Who, What, When, Where, Why
The program was launched at AIIMS Delhi’s Rotary Cancer Hospital. The da Vinci system enhances surgical precision in cancer procedures, particularly targeting difficult-to-treat organs such as the rectum, pancreas, esophagus, urology, and gynecologic sites. Over 100 surgeries were performed in the pilot phase, reflecting both clinical confidence and significant patient demand. The initiative is pivotal as India faces rising cancer rates and increasing demand for advanced, equitable treatment solutions.
Key Findings and Developments
-
AIIMS Delhi’s Department of Surgical Oncology now has five trained surgeons proficient in robotic-assisted surgery and has already completed approximately 100 procedures during the system’s pilot phase.
-
The program covers complex operations, including very low rectal surgeries, Whipple’s procedures for pancreatic cancer, and advanced chest interventions.
-
All robotic-assisted surgeries at AIIMS Delhi are provided free of charge, removing financial barriers and enabling access for patients from all socioeconomic backgrounds.
Expert Commentary
Dr. M. Srinivas, Director of AIIMS Delhi, explained, “The introduction of robotic-assisted surgery reflects AIIMS Delhi’s mission to expand equitable access to advanced healthcare. With cancer cases increasing nationwide, the need for precision-driven treatment is greater than ever. As a referral center for highly complex cases, this technology enables AIIMS to offer meaningful advancements in patient care”.
Dr. Sunil Kumar, Head of the Department of Surgical Oncology, added, “Robotic-assisted surgery is transforming complex cancer treatment by giving patients smaller incisions, reduced blood loss, less pain, faster recovery, and fewer complications.” He emphasized that surgeons benefit from enhanced visibility and control, resulting in high-accuracy interventions. “With this program, AIIMS Delhi is setting new benchmarks for oncology surgery in the public sector and widening access to cutting-edge treatment for people across the country”.
Dr. Anjali Shah, a surgical oncologist at a private hospital (not associated with the program), commented, “Robotic surgery is an exciting development for Indian cancer care. Global studies have shown that minimally invasive robotic procedures can reduce surgical trauma and hospital stays for patients with complex cancers, though long-term outcomes and cost-effectiveness must continue to be rigorously tracked.”
Context and Background
Robotic-assisted surgery, especially using systems like da Vinci, represents a growing trend in oncologic care. Globally, studies published in peer-reviewed medical journals have shown significant benefits for select patient populations, including fewer post-operative complications and hospital stays. However, access is often limited by cost—making AIIMS Delhi’s free-of-charge offering unique within the Indian public health sector.
According to the World Health Organization, cancer is a leading cause of death in India, accounting for approximately 8-9% of all deaths annually. In 2022, over 1.4 million new cancer cases were reported nationwide, driving demand for innovative, patient-centered treatment strategies (WHO Cancer Country Profiles 2023).
Implications for Public Health
Accessible robotic surgery at a high-volume, government-run facility like AIIMS Delhi has multiple implications:
-
It democratizes access to cutting-edge technology that was previously available mostly in private hospitals at high cost.
-
Public-sector adoption ensures that research and documented outcomes can inform best practices across India, potentially benefitting millions.
-
If outcomes match international benchmarks, it may encourage other government hospitals to adopt similar strategies, expanding equitable cancer care.
Potential Limitations and Counterarguments
While robotic-assisted surgery offers numerous patient and surgeon benefits, it is not universally suitable. According to recent studies published in The Lancet Oncology (2023), the long-term survival benefits for certain cancer types compared to traditional surgery remain under investigation. Additionally, high equipment and training costs mean that program scalability is dependent on sustained funding and skilled workforce development.
Dr. Nikhil Sharma, a surgical robotics specialist (unaffiliated with AIIMS), cautions, “While robotic systems represent the future, cost-effectiveness and access in lower-resource settings are ongoing concerns. It’s crucial to ensure that technology integration does not inadvertently sideline traditional techniques that remain essential for Indian hospitals with limited resources.”
Practical Health Implications for Readers
The launch of robotic surgery at AIIMS Delhi means eligible cancer patients—regardless of income—can access minimally invasive treatments associated with less pain, faster recovery, and reduced hospital stays. Prospective patients must consult their oncologist to understand whether robotic surgery is appropriate for their specific condition, as not all cancers or health profiles suit this approach. All procedures are currently provided free of cost at AIIMS, underscoring a significant step forward in equitable healthcare delivery.
Balanced Reporting and Ongoing Developments
AIIMS Delhi plans to expand the program by further documenting patient outcomes and sharing learnings through research and collaborations. As the healthcare system evolves, it remains essential that new technologies are rigorously evaluated and adapted to serve both clinical efficacy and public health goals.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
AIIMS Delhi launches advanced robotic surgery program for cancer care. Health Economic Times. Published September 2025.
- https://health.economictimes.indiatimes.com/news/hospitals/aiims-delhi-launches-advanced-robotic-surgery-program-for-cancer-care/124192039?utm_source=top_story&utm_medium=homepage
